Work

Improvements in Health-Related Quality of Life and Symptoms in Patients with Previously Untreated Chronic Lymphocytic Leukemia: Final Results from the Phase II GIBB Study of the Combination of Obinutuzumab and Bendamustine

Year: 2019

Type: conference-abstract

Source: Blood

DOI: 10.1182/blood-2019-123630

Authors: Alexey Danilov, Habte A Yimer, Michael Boxer, John M Burke, Sunil Babu, Jia Li, Yong Mun, Peter C Trask, Anthony S Masaquel, Jeff P. Sharman

Institutions: Oregon Health & Science University, Texas Oncology, Arizona Oncology, Rocky Mountain Cancer Centers, Fort Wayne Medical Institute, Genentech, Willamette Valley Cancer Institute and Research Center

Language: English

Topic: Chronic Lymphocytic Leukemia Research

Subfield: Genetics

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W4243387394

Cites:

Cited by: 1

Related to: 10